Regenstrief Institute, Inc.
🇺🇸United States
Clinical Trials
4
Active:0
Completed:3
Trial Phases
2 Phases
Early Phase 1:1
Not Applicable:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Not Applicable
3 (75.0%)Early Phase 1
1 (25.0%)Testing Utility of Commercially Available Sleep Trackers for Physician-Patient Communication
Not Applicable
- Conditions
- Insomnia
- First Posted Date
- 2019-01-07
- Last Posted Date
- 2019-01-07
- Lead Sponsor
- Regenstrief Institute, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT03795129
- Locations
- 🇺🇸
Regenstrief Institute, Indianapolis, Indiana, United States
HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
Not Applicable
Completed
- Conditions
- Human Papilloma Virus Infection Type 6Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18Cervical CancerGenital WartsOropharyngeal CancerHuman Papilloma Virus Infection Type 11
- First Posted Date
- 2015-09-24
- Last Posted Date
- 2016-05-25
- Lead Sponsor
- Regenstrief Institute, Inc.
- Target Recruit Count
- 1305
- Registration Number
- NCT02558803
- Locations
- 🇺🇸
Eskenazi Health Outpatient Care Center, Indianapolis, Indiana, United States
🇺🇸Eskenazi Health Center Blackburn, Indianapolis, Indiana, United States
🇺🇸Eskenazi Health Center Forest Manor, Indianapolis, Indiana, United States
HPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts
Not Applicable
Completed
- Conditions
- Genital WartsHuman Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 18Cervical CancerHuman Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 6Oropharyngeal Cancer
- First Posted Date
- 2015-09-16
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- Regenstrief Institute, Inc.
- Target Recruit Count
- 647
- Registration Number
- NCT02551887
Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine
Early Phase 1
Completed
- Conditions
- Human Papilloma Virus Infection Type 16Cervical CancerHuman Papilloma Virus Infection Type 6Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 18
- First Posted Date
- 2015-09-11
- Last Posted Date
- 2016-05-25
- Lead Sponsor
- Regenstrief Institute, Inc.
- Target Recruit Count
- 1306
- Registration Number
- NCT02546752
- Locations
- 🇺🇸
Eskenazi Health Outpatient Care Center, Indianapolis, Indiana, United States
🇺🇸Eskenazi Health Center Blackburn, Indianapolis, Indiana, United States
🇺🇸Eskenazi Health Center Forest Manor, Indianapolis, Indiana, United States
News
No news found